CYP24A1 splice variants—Implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer

This publication has 11 references indexed in Scilit:

• CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines
  The Journal of Steroid Biochemistry and Molecular Biology, 2007
• CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer
  International Journal of Cancer, 2006
• Expression of VDR and CYP24A1 mRNA in human tumors
  Cancer Chemotherapy and Pharmacology, 2005
• Alternative Splicing of Vitamin D-24-Hydroxylase
  Journal of Biological Chemistry, 2005
• Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue
  Clinical Cancer Research, 2005
• Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer
  Annals of Oncology, 2004
• Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences
  Proceedings of the National Academy of Sciences, 2002
• Clonal Differences in Expression of 25-Hydroxyvitamin D3-1α-hydroxylase, of 25-Hydroxyvitamin D3-24-hydroxylase, and of the Vitamin D Receptor in Human Colon Carcinoma Cells: Effects of Epidermal Growth Factor and 1α,25-Dihydroxyvitamin D3
  Experimental Cell Research, 2002
• Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
  Nature Genetics, 2000
• Expression and Activity of Vitamin D-Metabolizing Cytochrome P450s (CYP1 and CYP24) in Human Nonsmall Cell Lung Carcinomas
  Endocrinology, 1999